Home / Research and experimental development on biotechnology (except medical and veterinary science)

SINGAPORE HONGBO BIOTECHNOLOGY PTE. LTD.

Live CompanyUEN 202508787WLocal Company

SINGAPORE HONGBO BIOTECHNOLOGY PTE. LTD. is a local company in Singapore with UEN 202508787W. It was registered on 28 Feb 2025, 1 years ago. Its status is Live Company. Its main activity is research and experimental development on biotechnology (except medical and veterinary science).

UEN202508787W
StatusLive Company
Entity typeLocal Company, Exempt Private Company Limited by Shares
Registered28 Feb 2025
Main activity (SSIC)72101 Research and experimental development on biotechnology (except medical and veterinary science)
Secondary activity46649 Wholesale of chemicals and chemical products n.e.c.
Address60 PAYA LEBAR ROAD, #04-16, PAYA LEBAR SQUARE, Singapore 409051
21342 companies at this address
AreaGeylang · District 14 (Geylang, Eunos)
Nearest stationPaya Lebar MRT, about 66 m
Officers4

Newer companies in research and experimental development on biotechnology (except medical and veterinary science)

  • DAYOU BIOTECHNOLOGY PTE. LTD.202637714W · 18 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PROBIO TECHNOLOGY PRIVATE LIMITED202636974G · 13 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • NEUTHERA PTE. LTD.202636842M · 12 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PC BIOME INNOVATIONS PTE. LTD.202636514M · 11 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • THERALIFE53529115M · 1 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • BIO-SUPPLY INNOVATIONS PTE. LTD.202633668E · 24 Jul 2026 · Research and experimental development on biotechnology (except medical and veterinary science)

Source: ACRA open data, data date 16 Sep 2026. Directors, shareholders and financial statements are not in the open data.